Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (10)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fahy, R. J.
Right arrow Articles by Wewers, M. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fahy, R. J.
Right arrow Articles by Wewers, M. D.
(Chest. 2001;119:196-203.)
© 2001 American College of Chest Physicians

BAL and Serum IgG Levels in Healthy Asymptomatic HIV-Infected Patients*

Ruairi J. Fahy, MB; Philip T. Diaz, MD; Judith Hart, MS and Mark D. Wewers, MD

* From the Division of Pulmonary and Critical Care and The Heart Lung Institute, Department of Internal Medicine, The Ohio State University, Columbus, OH 43210.

Correspondence to: Mark D. Wewers, MD, Division of Pulmonary and Critical Care, Department of Internal Medicine, The Ohio State University, N-325 Means Hall, 1654 Upham Dr, Columbus, OH 43210; e-mail: wewers.2{at}osu.edu

Objectives: To determine if the increased susceptibility to bacterial infection in asymptomatic HIV-infected patients is associated with decreased total IgG or IgG2 levels in lung epithelial lining fluid.

Background: A decrease in lung IgG levels or subtypes has been proposed as contributing to the increased risk of bacterial lung infections in HIV-infected patients. Previous studies measuring lung lavage IgG concentrations have been inconsistent.

Methods: Twenty-three HIV patients and 25 control subjects underwent BAL. Both patient groups were of similar age, and had similar pulmonary function studies and body mass index. Smokers were equally represented in both groups, and the majority of subjects in both groups were male. Total IgG and IgG2 levels in lavage fluid were assayed in both cohorts and compared using a two-tailed Student’s t test.

Results: The lung lining fluid IgG level in HIV-infected patients was 0.19 ± 0.13 µg/µg of protein (mean ± SD) vs 0.11 ± 0.09 µg/µg of protein in control subjects (p < 0.05). The IgG2 level in HIV patients was 0.034 ± 0.038 µg/µg of protein and 0.014 ± 0.01 µg/µg of protein in control subjects (p = 0.054). Lavage IgG levels reflected serum IgG values (correlation coefficient, 0.56; p < 0.001) but did not correlate with lung immunoglobulin-producing cells.

Conclusions: The increased susceptibility to bacterial pneumonia in asymptomatic HIV-infected individuals is neither explained by depressed total IgG levels nor a deficiency in IgG2 levels in the lungs. The strong correlation between serum and lavage IgG levels suggests that lavage IgG derives from serum.

Key Words: BAL fluid • HIV infection • immunoglobulin




This article has been cited by other articles:


Home page
Ann Rheum DisHome page
F J Wiedermann
Alveolar and serum antiphospholipid antibodies in acute respiratory distress syndrome associated with catastrophic antiphospholipid syndrome
Ann Rheum Dis, March 1, 2006; 65(3): 413 - 413.
[Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
H. L. Twigg III
Humoral Immune Defense (Antibodies): Recent Advances
Proceedings of the ATS, December 1, 2005; 2(5): 417 - 421.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
J. M. Beck
The Immunocompromised Host: HIV Infection
Proceedings of the ATS, December 1, 2005; 2(5): 423 - 427.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
A. Elssner, J. E. Carter, T. M. Yunger, and M. D. Wewers
HIV-1 Infection Does Not Impair Human Alveolar Macrophage Phagocytic Function Unless Combined With Cigarette Smoking
Chest, March 1, 2004; 125(3): 1071 - 1076.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
F J Wiedermann, W Lederer, A J Mayr, N Sepp, M Herold, and W Schobersberger
Prospective observational study of antiphospholipid antibodies in acute lung injury and acute respiratory distress syndrome: comparison with catastrophic antiphospholipid syndrome
Lupus, June 1, 2003; 12(6): 462 - 467.
[Abstract] [PDF]


Home page
Eur Respir JHome page
C. Mayaud, A. Parrot, and J. Cadranel
Pyogenic bacterial lower respiratory tract infection in human immunodeficiency virus-infected patients
Eur. Respir. J., July 1, 2002; 20(36_suppl): 28S - 39s.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American College of Chest Physicians.